CRISPR Therapeutics AG (CRSP)
53.97
-1.11
(-2.02%)
USD |
NASDAQ |
Dec 29, 16:00
53.90
-0.07
(-0.13%)
After-Hours: 20:00
CRISPR Therapeutics Research and Development Expense (Quarterly): 54.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Intellia Therapeutics, Inc. | 92.33M |
| Novartis AG | 2.857B |
| Beam Therapeutics, Inc. | 109.77M |
| BeOne Medicines Ltd. | 505.41M |